Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa
Stuart H Isaacson, Julia Skettini Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, USA Abstract: Neurogenic orthostatic hypotension (nOH) is due to failure of the autonomic nervous system to regulate blood pressure in response to postural changes due to an i...
Main Authors: | Isaacson SH, Skettini J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-04-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/neurogenic-orthostatic-hypotension-in-parkinson39s-disease-evaluation--a16344 |
Similar Items
-
Neurogenic orthostatic hypotension – management update and role of droxidopa
by: Vijayan J, et al.
Published: (2015-06-01) -
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
by: Italo Biaggioni, et al.
Published: (2017-05-01) -
Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach
by: Amjad F, et al.
Published: (2021-08-01) -
Characterization of the changes in supine blood pressure with long‐term use of droxidopa in patients with neurogenic orthostatic hypotension
by: L. Arthur Hewitt, et al.
Published: (2021-03-01) -
The management of orthostatic hypotension in Parkinson's disease
by: Alvaro eSanchez-Ferro, et al.
Published: (2013-06-01)